Latest Articles
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study - Cureus
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study Cureus
Published: Dec. 4, 2025, 4:59 a.m.
GSK’s Jemperli now standard in endometrial cancer as reimbursement expands to 1st-line therapy - koreabiomed.com
GSK’s Jemperli now standard in endometrial cancer as reimbursement expands to 1st-line therapy koreabiomed.com
Published: Dec. 1, 2025, 6:49 a.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 25, 2025, 2:06 p.m.
ASTRO releases new radiation therapy guidelines for gastric cancers - Radiology Business
ASTRO releases new radiation therapy guidelines for gastric cancers Radiology Business
Published: Nov. 19, 2025, 7:35 p.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy - Endocrine Society
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy Endocrine Society
Published: Nov. 18, 2025, 9:22 a.m.
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative - Nature
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative Nature
Published: Nov. 11, 2025, 8:42 p.m.
"Black box" warning from menopause hormone therapy scrapped by FDA - Axios
"Black box" warning from menopause hormone therapy scrapped by FDA Axios
Published: Nov. 11, 2025, 4:54 p.m.
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy - GlobeNewswire
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy GlobeNewswire
Published: Nov. 6, 2025, 4 p.m.
Pelvic Floor Therapy for Endometriosis - HealthCentral
Pelvic Floor Therapy for Endometriosis HealthCentral
Published: Nov. 6, 2025, 12:44 p.m.
Merck secures $700 million funding from Blackstone to develop cancer therapy - ETPharma.com
Merck secures $700 million funding from Blackstone to develop cancer therapy ETPharma.com
Published: Nov. 5, 2025, 12:32 p.m.
Link copied to clipboard!